Clinical Trial Update: A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

BeOne Medicines is conducting a Phase 1b/2 trial of Sonrotoclax (BGB-11417) as a monotherapy and in combination with dexamethasone plus carfilzomib, dexamethaso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Pomalidomide (Pomalidomide)
• Sonrotoclax

Snippet

Sponsor: BeOne Medicines | Conditions: Relapsed/Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING